- In June 2024, RevelAi Health and Zimmer Biomet, a prominent MedTech company, entered into a multi-year co-marketing agreement aimed at commercializing generative artificial intelligence (AI)-driven engagement solutions to enhance value-based orthopedic care and promote health equity. As part of this collaboration, Zimmer Biomet intends to introduce RevelAi Health's care team dashboard and patient care management platform to the market. This partnership underscores the commitment of both companies to leverage innovative technology in improving patient outcomes and healthcare accessibility
- In July 2024, Stryker, a leader in medical technology innovation, finalized its acquisition of Artelon, Inc., a privately-owned company known for its expertise in soft tissue products designed primarily for foot and ankle as well as sports medicine procedures. This strategic acquisition aims to strengthen Stryker's product portfolio and enhance its capabilities in delivering advanced solutions for orthopedic care. By integrating Artelon’s offerings, Stryker is poised to better address the needs of healthcare providers and patients in these specialized fields
- In July 2024, Orthofix Medical Inc. obtained FDA clearance for its innovative Fitbone Transport and Lengthening System, a groundbreaking implant designed to address leg bone defects. This system stands out as it can lengthen or repair bone in a single surgical procedure, contrasting with conventional techniques that typically necessitate multiple surgeries. With this advancement, Orthofix aims to improve surgical outcomes and reduce recovery time for patients with leg bone issues
